img

Global Metabotropic Glutamate Receptor 2 Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Medical Devices & Consumables Research Center

Publisher : MRX | Format : PDF

Global Metabotropic Glutamate Receptor 2 Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Metabotropic Glutamate Receptor 2 Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Metabotropic Glutamate Receptor 2 industry at home and abroad, estimate the overall market scale of the Metabotropic Glutamate Receptor 2 industry and the market share of major countries, Metabotropic Glutamate Receptor 2 industry, and study and judge the downstream market demand of Metabotropic Glutamate Receptor 2 through systematic research, Analyze the competition pattern of Metabotropic Glutamate Receptor 2, so as to help solve the pain points of various stakeholders in Metabotropic Glutamate Receptor 2 industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Metabotropic Glutamate Receptor 2 Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Metabotropic Glutamate Receptor 2 Market?
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
...
Major Type of Metabotropic Glutamate Receptor 2 Covered in XYZResearch report
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Application Segments Covered in XYZResearch Market
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Metabotropic Glutamate Receptor 2 Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Metabotropic Glutamate Receptor 2 Market by Value
2.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type
2.2.2 Global Metabotropic Glutamate Receptor 2 Market by Value (%)
2.3 Global Metabotropic Glutamate Receptor 2 Market by Production
2.3.1 Global Metabotropic Glutamate Receptor 2 Production by Type
2.3.2 Global Metabotropic Glutamate Receptor 2 Market by Production (%)

3. The Major Driver of Metabotropic Glutamate Receptor 2 Industry
3.1 Historical & Forecast Global Metabotropic Glutamate Receptor 2 Demand
3.2 Largest Application for Metabotropic Glutamate Receptor 2 (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Metabotropic Glutamate Receptor 2 Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Metabotropic Glutamate Receptor 2 Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Metabotropic Glutamate Receptor 2 Average Price Trend
12.1 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in US (2018-2022)
12.2 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in Europe (2018-2022)
12.3 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in China (2018-2022)
12.4 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in Japan (2018-2022)
12.5 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in India (2018-2022)
12.6 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in Korea (2018-2022)
12.7 Market Price for Each Type of Metabotropic Glutamate Receptor 2 in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Metabotropic Glutamate Receptor 2 Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Metabotropic Glutamate Receptor 2

14. Metabotropic Glutamate Receptor 2 Competitive Landscape
14.1 Addex Therapeutics Ltd
14.1.1 Addex Therapeutics Ltd Company Profiles
14.1.2 Addex Therapeutics Ltd Product Introduction
14.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Bristol-Myers Squibb Company
14.2.1 Bristol-Myers Squibb Company Company Profiles
14.2.2 Bristol-Myers Squibb Company Product Introduction
14.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Denovo Biopharma LLC
14.3.1 Denovo Biopharma LLC Company Profiles
14.3.2 Denovo Biopharma LLC Product Introduction
14.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Domain Therapeutics SA
14.4.1 Domain Therapeutics SA Company Profiles
14.4.2 Domain Therapeutics SA Product Introduction
14.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Eli Lilly and Company
14.5.1 Eli Lilly and Company Company Profiles
14.5.2 Eli Lilly and Company Product Introduction
14.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Johnson & Johnson
14.6.1 Johnson & Johnson Company Profiles
14.6.2 Johnson & Johnson Product Introduction
14.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Merck & Co Inc
14.7.1 Merck & Co Inc Company Profiles
14.7.2 Merck & Co Inc Product Introduction
14.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 ...
14.8.1 ... Company Profiles
14.8.2 ... Product Introduction
14.8.3 ... Metabotropic Glutamate Receptor 2 Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Metabotropic Glutamate Receptor 2 Industry (Volume)
Figure 2. Metabotropic Glutamate Receptor 2 Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 2 Revenue in 2022
Figure 5. US Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Metabotropic Glutamate Receptor 2 Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Metabotropic Glutamate Receptor 2 Revenue, by Type (Million USD) (2018-2028)
Table 4. Metabotropic Glutamate Receptor 2 Production, by Type (K Unit) (2018-2028)
Table 5. Metabotropic Glutamate Receptor 2 Demand (K Unit) by Application (2018-2028)
Table 6. Metabotropic Glutamate Receptor 2 Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Metabotropic Glutamate Receptor 2 Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Metabotropic Glutamate Receptor 2 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Metabotropic Glutamate Receptor 2 in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Addex Therapeutics Ltd Profiles
Table 61. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Introduction
Table 62. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Addex Therapeutics Ltd Strategic initiatives
Table 64. Bristol-Myers Squibb Company Profiles
Table 65. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Introduction
Table 66. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Bristol-Myers Squibb Company Strategic initiatives
Table 68. Denovo Biopharma LLC Profiles
Table 69. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Introduction
Table 70. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Denovo Biopharma LLC Strategic initiatives
Table 72. Domain Therapeutics SA Profiles
Table 73. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Introduction
Table 74. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Domain Therapeutics SA Strategic initiatives
Table 76. Eli Lilly and Company Profiles
Table 77. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Introduction
Table 78. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Eli Lilly and Company Strategic initiatives
Table 80. Johnson & Johnson Profiles
Table 81. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Introduction
Table 82. Johnson & Johnson Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Johnson & Johnson Strategic initiatives
Table 84. Merck & Co Inc Profiles
Table 85. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Introduction
Table 86. Merck & Co Inc Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Merck & Co Inc Strategic initiatives
Table 88. ... Profiles
Table 89. ... Metabotropic Glutamate Receptor 2 Product Introduction
Table 90. ... Metabotropic Glutamate Receptor 2 Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. ... Strategic initiatives